- Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells
-
Kumar A, Bhatkar D, Jahagirdar D, Sharma NK
- KMID: 2375548
- J Cancer Prev.
- 2017 Mar;22(1):47-54.
- doi: 10.15430/JCP.2017.22.1.47
Among the genotoxic drug regimens, doxorubicin (DOX) is known for its high-dose side effects in several carcinomas, including cervical cancer. This study reports on testing the combined use of a... -
- CITED
-
- Close
- SHARE
-
- Close
